Clinical Trials for Non-alcoholic Fatty Liver Disease (NAFLD)

Evaluation of Miricorilant on Liver Fat in Patients With MASLD

NCT ID: NCT06947304

This clinical trial is studying a new treatment called Miricorilant to see how it affects liver fat in patients with a condition known as Metabolic Dysfunction-Associated Steatohepatitis (MASH), wh...

Elucidating Hepatic Metabolism in Non-alcoholic Fatty Liver Disease

NCT ID: NCT06942312

Screening in Primary Care of Advanced Liver Fibrosis in NAFLD And/or Alcoholic Patients

NCT ID: NCT05699018

The SOPRANO study is a clinical trial that is looking at two different blood tests, called eLIFT and FibroMeter, to see which one works better for checking advanced liver fibrosis in patients with ...

Effectiveness of Nutrition Education Program and Omega-3 Supplementation Among Non-alcoholic Fatty Liver Disease Patients

NCT ID: NCT06627114

This clinical trial is looking at how a nutrition education program and omega-3 supplements might help people with non-alcoholic fatty liver disease (NAFLD). The researchers want to see if these ap...

Integrated Phenotyping of the Gut-plAtelet-Liver AXIS in the Progression of Chronic Liver Disease (iGAL-AXIS)

NCT ID: NCT06623084

The iGAL-AXIS clinical trial is investigating how certain blood cells called platelets, which can be affected by substances from the gut, influence the progression of liver diseases like Non-alcoho...

Simultaneous Quantification of Liver Fat Content, Fatty Acid Composition, and Fibrosis Using Spin-lock MRI for Steatohepatitis Assessment

NCT ID: NCT05384652

This clinical trial is exploring a new way to assess non-alcoholic fatty liver disease (NAFLD), specifically focusing on conditions known as simple steatosis and non-alcoholic steatohepatitis (NASH...